Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

terminatednot_applicable

Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

NCT03945058

completednot_applicable

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function in PAD

NCT03445754

completednot_applicable

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function and Arterial Stiffness in HFrEF

NCT03380156

completednot_applicable

An Investigation With an Intra-vaginal Device for Stress Urinary Incontinence

NCT03186651

Clinical Trials (4)

Showing 4 of 4 trials

NCT03945058Not Applicable

Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

Terminated

NCT03445754Not Applicable

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function in PAD

Completed

NCT03380156Not Applicable

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function and Arterial Stiffness in HFrEF

Completed

NCT03186651Not Applicable

An Investigation With an Intra-vaginal Device for Stress Urinary Incontinence

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4